Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 52

1.

Careful neuropsychological testing reveals a novel genetic marker, GSTO1*C, linked to the pre-stage of Alzheimer's disease.

Umlauf E, Rappold E, Schiller B, Fuchs P, Rainer M, Wolf B, Zellner M.

Oncotarget. 2016 Jun 28;7(26):39108-39117. doi: 10.18632/oncotarget.9773.

2.

The Genetic Architecture of Murine Glutathione Transferases.

Lu L, Pandey AK, Houseal MT, Mulligan MK.

PLoS One. 2016 Feb 1;11(2):e0148230. doi: 10.1371/journal.pone.0148230.

3.

GSTP1 and GSTO1 single nucleotide polymorphisms and the response of bladder cancer patients to intravesical chemotherapy.

Deng X, Yang X, Cheng Y, Liu X, Li X, Zhao R, Qin C, Lu Q, Yin C.

Sci Rep. 2015 Sep 10;5:14000. doi: 10.1038/srep14000.

4.

Family Wide Molecular Adaptations to Underground Life in African Mole-Rats Revealed by Phylogenomic Analysis.

Davies KT, Bennett NC, Tsagkogeorga G, Rossiter SJ, Faulkes CG.

Mol Biol Evol. 2015 Dec;32(12):3089-107. doi: 10.1093/molbev/msv175.

5.

Microglial cell dysregulation in brain aging and neurodegeneration.

von Bernhardi R, Eugenín-von Bernhardi L, Eugenín J.

Front Aging Neurosci. 2015 Jul 20;7:124. doi: 10.3389/fnagi.2015.00124. Review.

6.

Effects of GSTM1/GSTT1 gene polymorphism and fruit & vegetable consumption on antioxidant biomarkers and cognitive function in the elderly: a community based cross-sectional study.

Yuan L, Ma W, Liu J, Meng L, Liu J, Li S, Han J, Liu Q, Feng L, Wang C, Xiao R.

PLoS One. 2014 Nov 24;9(11):e113588. doi: 10.1371/journal.pone.0113588.

7.

A platelet protein biochip rapidly detects an Alzheimer's disease-specific phenotype.

Veitinger M, Oehler R, Umlauf E, Baumgartner R, Schmidt G, Gerner C, Babeluk R, Attems J, Mitulovic G, Rappold E, Lamont J, Zellner M.

Acta Neuropathol. 2014 Nov;128(5):665-77. doi: 10.1007/s00401-014-1341-8.

8.

Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.

Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YS, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang LS, Kauwe JS, Huentelman MJ, Myers AJ, Bird TD, Boeve BF, Baldwin CT, Jarvik GP, Crane PK, Rogaeva E, Barmada MM, Demirci FY, Cruchaga C, Kramer PL, Ertekin-Taner N, Hardy J, Graff-Radford NR, Green RC, Larson EB, St George-Hyslop PH, Buxbaum JD, Evans DA, Schneider JA, Lunetta KL, Kamboh MI, Saykin AJ, Reiman EM, De Jager PL, Bennett DA, Morris JC, Montine TJ, Goate AM, Blacker D, Tsuang DW, Hakonarson H, Kukull WA, Foroud TM, Martin ER, Haines JL, Mayeux RP, Farrer LA, Schellenberg GD, Pericak-Vance MA; Alzheimer Disease Genetics Consortium., Albert MS, Albin RL, Apostolova LG, Arnold SE, Barber R, Barnes LL, Beach TG, Becker JT, Beekly D, Bigio EH, Bowen JD, Boxer A, Burke JR, Cairns NJ, Cantwell LB, Cao C, Carlson CS, Carney RM, Carrasquillo MM, Carroll SL, Chui HC, Clark DG, Corneveaux J, Cribbs DH, Crocco EA, DeCarli C, DeKosky ST, Dick M, Dickson DW, Duara R, Faber KM, Fallon KB, Farlow MR, Ferris S, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Glass JD, Growdon JH, Hamilton RL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jicha GA, Jin LW, Karydas A, Kaye JA, Kim R, Koo EH, Kowall NW, Kramer JH, LaFerla FM, Lah JJ, Leverenz JB, Levey AI, Li G, Lieberman AP, Lin CF, Lopez OL, Lyketsos CG, Mack WJ, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Murrell JR, Olichney JM, Pankratz VS, Parisi JE, Paulson HL, Peskind E, Petersen RC, Pierce A, Poon WW, Potter H, Quinn JF, Raj A, Raskind M, Reisberg B, Ringman JM, Roberson ED, Rosen HJ, Rosenberg RN, Sano M, Schneider LS, Seeley WW, Smith AG, Sonnen JA, Spina S, Stern RA, Tanzi RE, Thornton-Wells TA, Trojanowski JQ, Troncoso JC, Valladares O, Van Deerlin VM, Van Eldik LJ, Vardarajan BN, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Williamson J, Wishnek S, Woltjer RL, Wright CB, Younkin SG, Yu CE, Yu L.

JAMA Neurol. 2014 Nov;71(11):1394-404. doi: 10.1001/jamaneurol.2014.1491. Erratum in: JAMA Neurol. 2014 Nov;71(11):1457.

9.

Characterization and mutational analysis of omega-class GST (GSTO1) from Apis cerana cerana, a gene involved in response to oxidative stress.

Meng F, Zhang Y, Liu F, Guo X, Xu B.

PLoS One. 2014 Mar 25;9(3):e93100. doi: 10.1371/journal.pone.0093100.

10.

A role for glutathione transferase Omega 1 (GSTO1-1) in the glutathionylation cycle.

Menon D, Board PG.

J Biol Chem. 2013 Sep 6;288(36):25769-79. doi: 10.1074/jbc.M113.487785.

11.

Genetic analysis of interferon induced thyroiditis (IIT): evidence for a key role for MHC and apoptosis related genes and pathways.

Hasham A, Zhang W, Lotay V, Haggerty S, Stefan M, Concepcion E, Dieterich DT, Tomer Y.

J Autoimmun. 2013 Aug;44:61-70. doi: 10.1016/j.jaut.2013.04.002.

12.

Alternative Approaches in Gene Discovery and Characterization in Alzheimer's Disease.

Ertekin-Taner N, De Jager PL, Yu L, Bennett DA.

Curr Genet Med Rep. 2013 Mar;1(1):39-51.

13.

A novel Omega-class glutathione S-transferase gene in Apis cerana cerana: molecular characterisation of GSTO2 and its protective effects in oxidative stress.

Zhang Y, Yan H, Lu W, Li Y, Guo X, Xu B.

Cell Stress Chaperones. 2013 Jul;18(4):503-16. doi: 10.1007/s12192-013-0406-2.

14.

Interactogeneous: disease gene prioritization using heterogeneous networks and full topology scores.

Gonçalves JP, Francisco AP, Moreau Y, Madeira SC.

PLoS One. 2012;7(11):e49634. doi: 10.1371/journal.pone.0049634.

15.

Tyrosine hydroxylase gene: another piece of the genetic puzzle of Parkinson's disease.

Bademci G, Vance JM, Wang L.

CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):469-81. Review.

16.

Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications.

Allen M, Zou F, Chai HS, Younkin CS, Miles R, Nair AA, Crook JE, Pankratz VS, Carrasquillo MM, Rowley CN, Nguyen T, Ma L, Malphrus KG, Bisceglio G, Ortolaza AI, Palusak R, Middha S, Maharjan S, Georgescu C, Schultz D, Rakhshan F, Kolbert CP, Jen J, Sando SB, Aasly JO, Barcikowska M, Uitti RJ, Wszolek ZK, Ross OA, Petersen RC, Graff-Radford NR, Dickson DW, Younkin SG, Ertekin-Taner N.

Mol Neurodegener. 2012 Apr 11;7:13. doi: 10.1186/1750-1326-7-13.

17.

Induction of phase 2 antioxidant enzymes by broccoli sulforaphane: perspectives in maintaining the antioxidant activity of vitamins a, C, and e.

Boddupalli S, Mein JR, Lakkanna S, James DR.

Front Genet. 2012 Jan 24;3:7. doi: 10.3389/fgene.2012.00007.

18.

Glutathione s-transferase omega 1 activity is sufficient to suppress neurodegeneration in a Drosophila model of Parkinson disease.

Kim K, Kim SH, Kim J, Kim H, Yim J.

J Biol Chem. 2012 Feb 24;287(9):6628-41. doi: 10.1074/jbc.M111.291179.

19.

Gene expression endophenotypes: a novel approach for gene discovery in Alzheimer's disease.

Ertekin-Taner N.

Mol Neurodegener. 2011 May 14;6:31. doi: 10.1186/1750-1326-6-31.

20.

Vitamin D receptor gene as a candidate gene for Parkinson disease.

Butler MW, Burt A, Edwards TL, Zuchner S, Scott WK, Martin ER, Vance JM, Wang L.

Ann Hum Genet. 2011 Mar;75(2):201-10. doi: 10.1111/j.1469-1809.2010.00631.x.

Supplemental Content

Support Center